EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The Pathological Nexus and Multipronged Approaches to Mitigate Ferroptosis and Alzheimer’s Disease

Hariharan Moorthy iD, Shreyasri Sain, Dikshaa Padhi, Thimmaiah Govindaraju iD

Journal of Medicinal Chemistry · 09.10.2025 · 68 (19) · 19828-19845

DOI: 10.1021/acs.jmedchem.5c00917 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 26.09.2025. Verfasst von Hariharan Moorthy und 3 weiteren Autor:innen. Beteiligte Einrichtung: Bioorganic Chemistry Laboratory, New Chemistry Unit, Jawaharlal Nehru Centre for Advanced Scientific Research, Bengaluru, Karnataka 560064, India. Hauptthemen laut MEDLINE: Alzheimer Disease, Ferroptosis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 153 Literaturangaben. Gefördert von: Science and Engineering Research Board, Department of Science and Technology, Ministry of Science and Technology, India, Jawaharlal Nehru Centre for Advanced Scientific Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is a multifaceted neurodegenerative disorder and a leading cause of dementia. Although the amyloid cascade is a defining feature of AD pathology, the precise mechanisms underlying neurodegeneration remain unclear, and current therapeutics targeting this have shown limited efficacy. Emerging evidence implicates ferroptosis, an iron-dependent, lipid peroxidation (LPO)-driven form of regulated cell death, as a contributing factor in AD-related neuronal loss. Core biomarkers of ferroptosis, including iron dyshomeostasis, LPO, and reduced antioxidant capacity, closely align with hallmark features of AD suggesting a pathological nexus further supported by clinical evidence. While the use of LPO inhibitors and iron chelators has shown promising outcomes, there remains a significant gap in targeting key ferroptosis regulators, such as GPX4 and FSP1, which hold strong therapeutic potential in AD. This perspective explores their pathological interplay and offers strategic insights for the development of hybrid multifunctional therapeutic molecules to synergistically target these interconnected pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseFerroptosisAnimalsHumansIronIron Chelating AgentsLipid PeroxidationS100 Calcium-Binding Protein A4Phospholipid Hydroperoxide Glutathione Peroxidase

Substanzen

IronIron Chelating AgentsGPX4 protein, humanS100A4 protein, humanS100 Calcium-Binding Protein A4Phospholipid Hydroperoxide Glutathione Peroxidase

Autor:innen und Institutionen

  • Bioorganic Chemistry Laboratory, New Chemistry Unit, Jawaharlal Nehru Centre for Advanced Scientific Research, Bengaluru, Karnataka 560064, India.

ORCID-Profile: Hariharan Moorthy, Thimmaiah Govindaraju

Förderung

  • Science and Engineering Research Board
  • Department of Science and Technology, Ministry of Science and Technology, India
  • Jawaharlal Nehru Centre for Advanced Scientific Research

Zitieren

APA

Moorthy, H., Sain, S., Padhi, D., & Govindaraju, T. (2025). The Pathological Nexus and Multipronged Approaches to Mitigate Ferroptosis and Alzheimer’s Disease. Journal of Medicinal Chemistry, 68(19), 19828-19845. https://doi.org/10.1021/acs.jmedchem.5c00917

Vancouver

Moorthy H, Sain S, Padhi D, Govindaraju T. The Pathological Nexus and Multipronged Approaches to Mitigate Ferroptosis and Alzheimer’s Disease. Journal of Medicinal Chemistry. 2025;68(19):19828-19845. doi:10.1021/acs.jmedchem.5c00917

BibTeX
@article{Moorthy2025,
  author = {Moorthy, Hariharan and Sain, Shreyasri and Padhi, Dikshaa and Govindaraju, Thimmaiah},
  title = {The Pathological Nexus and Multipronged Approaches to Mitigate Ferroptosis and Alzheimer’s Disease},
  journal = {Journal of Medicinal Chemistry},
  year = {2025},
  volume = {68},
  number = {19},
  pages = {19828--19845},
  doi = {10.1021/acs.jmedchem.5c00917}
}
Kostenlos starten →